Vaccine Development Against COVID-19 Prior to Pandemic Outbreaks, Using Evolution and Reverse Genetics

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2020 Sep 14

PMID 32922408

Citations 1

Authors

Hatem Zayed

Affiliations

Soon will be listed here.

Citing Articles

SARS-CoV-2 viral budding and entry can be modeled using BSL-2 level virus-like particles.

Plescia C, David E, Patra D, Sengupta R, Amiar S, Su Y J Biol Chem. 2020; 296:100103.

PMID: 33214224 PMC: 7832013. DOI: 10.1074/jbc.RA120.016148.

References

Lu R, Zhao X, Li J, Niu P, Yang B, Wu H . Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020; 395(10224):565-574. PMC: 7159086. DOI: 10.1016/S0140-6736(20)30251-8. View

Zhu N, Zhang D, Wang W, Li X, Yang B, Song J . A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020; 382(8):727-733. PMC: 7092803. DOI: 10.1056/NEJMoa2001017. View

Ahmed S, Quadeer A, McKay M . Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies. Viruses. 2020; 12(3). PMC: 7150947. DOI: 10.3390/v12030254. View

Stobart C, Moore M . RNA virus reverse genetics and vaccine design. Viruses. 2014; 6(7):2531-50. PMC: 4113782. DOI: 10.3390/v6072531. View

Fan Y, Zhao K, Shi Z, Zhou P . Bat Coronaviruses in China. Viruses. 2019; 11(3). PMC: 6466186. DOI: 10.3390/v11030210. View

Moingeon P, Almond J, de Wilde M . Therapeutic vaccines against infectious diseases. Curr Opin Microbiol. 2003; 6(5):462-71. DOI: 10.1016/j.mib.2003.08.002. View

McBurney S, Young K, Ross T . Membrane embedded HIV-1 envelope on the surface of a virus-like particle elicits broader immune responses than soluble envelopes. Virology. 2006; 358(2):334-46. DOI: 10.1016/j.virol.2006.08.032. View

Wu F, Zhao S, Yu B, Chen Y, Wang W, Song Z . A new coronavirus associated with human respiratory disease in China. Nature. 2020; 579(7798):265-269. PMC: 7094943. DOI: 10.1038/s41586-020-2008-3. View

Baranyi L, Doering C, Denning G, Gautney R, Harris K, Spencer H . Rapid generation of stable cell lines expressing high levels of erythropoietin, factor VIII, and an antihuman CD20 antibody using lentiviral vectors. Hum Gene Ther Methods. 2013; 24(4):214-27. DOI: 10.1089/hgtb.2013.002. View

10.

Xu L, Bao L, Lau S, Wu W, Yuan J, Gu S . Hemagglutinin amino acids related to receptor specificity could affect the protection efficacy of H5N1 and H7N9 avian influenza virus vaccines in mice. Vaccine. 2016; 34(23):2627-33. DOI: 10.1016/j.vaccine.2016.03.031. View

11.

Walls A, Park Y, Tortorici M, Wall A, McGuire A, Veesler D . Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein. Cell. 2020; 181(2):281-292.e6. PMC: 7102599. DOI: 10.1016/j.cell.2020.02.058. View

12.

Kaye M . SARS-associated coronavirus replication in cell lines. Emerg Infect Dis. 2006; 12(1):128-33. PMC: 3291385. DOI: 10.3201/eid1201.050496. View

13.

de Wispelaere M, Ricklin M, Souque P, Frenkiel M, Paulous S, Garcia-Nicolas O . A Lentiviral Vector Expressing Japanese Encephalitis Virus-like Particles Elicits Broad Neutralizing Antibody Response in Pigs. PLoS Negl Trop Dis. 2015; 9(10):e0004081. PMC: 4593544. DOI: 10.1371/journal.pntd.0004081. View

14.

Rigouin C, Nguyen H, Schalk A, Lavie A . Discovery of human-like L-asparaginases with potential clinical use by directed evolution. Sci Rep. 2017; 7(1):10224. PMC: 5579231. DOI: 10.1038/s41598-017-10758-4. View

15.

Muratori C, Bona R, Federico M . Lentivirus-based virus-like particles as a new protein delivery tool. Methods Mol Biol. 2010; 614:111-24. DOI: 10.1007/978-1-60761-533-0_7. View

16.

Ivics Z, Kaufman C, Zayed H, Miskey C, Walisko O, Izsvak Z . The Sleeping Beauty transposable element: evolution, regulation and genetic applications. Curr Issues Mol Biol. 2003; 6(1):43-55. View

17.

Cui J, Li F, Shi Z . Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol. 2018; 17(3):181-192. PMC: 7097006. DOI: 10.1038/s41579-018-0118-9. View

18.

Thompson C, Aucoin M, Kamen A . Production of Virus-Like Particles for Vaccination. Methods Mol Biol. 2016; 1350:299-315. DOI: 10.1007/978-1-4939-3043-2_14. View

19.

Fontana D, Etcheverrigaray M, Kratje R, Prieto C . Development of Rabies Virus-Like Particles for Vaccine Applications: Production, Characterization, and Protection Studies. Methods Mol Biol. 2016; 1403:155-66. DOI: 10.1007/978-1-4939-3387-7_7. View

20.

Kikuchi M, Harayama S . DNA shuffling and family shuffling for in vitro gene evolution. Methods Mol Biol. 2002; 182:243-57. DOI: 10.1385/1-59259-194-9:243. View